NCT06420921

MeasurIng and Restoring Auditory Awareness for Cochlear Implant Listeners in noisE

Institut Pasteur·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Cochlear Hearing Loss
Drug/Device/Intervention
Speech in noise comprehension test
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Institut Pasteur
Location
Paris, France
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2024
End date
Jul 01, 2026
Enrollment
50 participants
Primary outcome

percentage of environmental sound cues correctly identified when presented simultaneously with other signals

Summary

The goal of this interventional study is to describe how people with cochlear implants
 perceive the perceive speech in noise and their sound environment on adults who are native
 French speakers with typical hearing or with cochlear implant(s).
 
 The measures and strategies developed in this project could benefit all current and future
 cochlear implant wearers by improving their perception of the sound environment and their
 quality of life on a daily basis.
 
 Researchers will compare normal hearing participant and participants with cochlear implant to
 describe the speech in noise and their perception of the sound environment.
 
 Participants will perform audiological tests to assess their perception of the sound
 environment, with and without speech enhancement.

ICD-10 classifications
Other hearing lossOther specified hearing lossOtotoxic hearing lossHearing loss, unspecifiedSudden idiopathic hearing loss
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06420921
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06420921 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut Pasteur and is currently Not yet recruiting. The study focuses on Cochlear Hearing Loss. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.